-
-
Call more information
660-596-2224 -
DG Alerts Findings from a UK study published in The Lancet Oncology indicate that cancer patients with different tumour types have variable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) susceptibility and coronavirus disease 2019 (COVID-19) phenotypes. In particular, patients with haematological cancers (leukaemia, lymphoma, or myeloma) had increased susceptibility to the virus, and were at greater risk […]
Read MoreDG Alerts According to data from an open-label Phase III study published in the Journal of the American Medical Association, patients with moderate coronavirus disease 2019 (COVID-19) pneumonia randomized to receive remdesivir treatment for up to 5 days had significantly higher odds of achieving clinical improvement at the 11-day mark than those receiving standard care. However, […]
Read MoreAuthor: Michael Walter Cardiovascular Business News Antihypertensive medications can improve COVID-19 survival rates and reduce the likelihood of severe illness, according to a new meta-analysis published in Current Atherosclerosis Reports. The study’s authors explored data from 19 different studies, focusing on the impact of renin-angiotensin-aldosterone system (RAAS) inhibitors such as angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-receptor […]
Read MoreI want to thank all of our readers a fun and happy labor day. Please be safe
Read MoreAuthor: Michael Walter Cardiovascular Business News Blood pressure variability (BPV) from one visit to the next is associated with cognitive decline and even dementia, according to a new study published in Hypertension. “The clinical relevance of BPV has not been considered until recently,” wrote lead author Laure Rouch, PhD, PharmD, Paris Descartes University in France, […]
Read More